17-41819306-TC-TCC

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_021939.4(FKBP10):​c.831dupC​(p.Gly278ArgfsTer95) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000967 in 1,613,250 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000091 ( 0 hom. )

Consequence

FKBP10
NM_021939.4 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:19U:1

Conservation

PhyloP100: -0.727
Variant links:
Genes affected
FKBP10 (HGNC:18169): (FKBP prolyl isomerase 10) The protein encoded by this gene belongs to the FKBP-type peptidyl-prolyl cis/trans isomerase (PPIase) family. This protein localizes to the endoplasmic reticulum and acts as a molecular chaperone. Alternatively spliced variants encoding different isoforms have been reported, but their biological validity has not been determined.[provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-41819306-T-TC is Pathogenic according to our data. Variant chr17-41819306-T-TC is described in ClinVar as [Pathogenic]. Clinvar id is 438659.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FKBP10NM_021939.4 linkc.831dupC p.Gly278ArgfsTer95 frameshift_variant Exon 5 of 10 ENST00000321562.9 NP_068758.3 Q96AY3-1A0A024R1W3Q8NAG5Q658U4
FKBP10XM_011525099.4 linkc.831dupC p.Gly278ArgfsTer95 frameshift_variant Exon 5 of 11 XP_011523401.1
FKBP10XM_011525100.3 linkc.558dupC p.Gly187ArgfsTer95 frameshift_variant Exon 4 of 10 XP_011523402.1
FKBP10XM_047436515.1 linkc.558dupC p.Gly187ArgfsTer95 frameshift_variant Exon 4 of 9 XP_047292471.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FKBP10ENST00000321562.9 linkc.831dupC p.Gly278ArgfsTer95 frameshift_variant Exon 5 of 10 1 NM_021939.4 ENSP00000317232.4 Q96AY3-1

Frequencies

GnomAD3 genomes
AF:
0.000152
AC:
23
AN:
151466
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000364
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000390
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000952
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000589
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000108
AC:
27
AN:
250308
Hom.:
0
AF XY:
0.0000811
AC XY:
11
AN XY:
135638
show subpopulations
Gnomad AFR exome
AF:
0.000498
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.0000797
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000910
AC:
133
AN:
1461670
Hom.:
0
Cov.:
32
AF XY:
0.0000921
AC XY:
67
AN XY:
727122
show subpopulations
Gnomad4 AFR exome
AF:
0.000627
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.000244
Gnomad4 NFE exome
AF:
0.0000719
Gnomad4 OTH exome
AF:
0.000149
GnomAD4 genome
AF:
0.000152
AC:
23
AN:
151580
Hom.:
0
Cov.:
31
AF XY:
0.000122
AC XY:
9
AN XY:
74042
show subpopulations
Gnomad4 AFR
AF:
0.000363
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000390
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000952
Gnomad4 NFE
AF:
0.0000589
Gnomad4 OTH
AF:
0.000474
Bravo
AF:
0.000132
EpiCase
AF:
0.000109
EpiControl
AF:
0.000119

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:19Uncertain:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Osteogenesis imperfecta type 11 Pathogenic:8Uncertain:1
-
3billion
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.011%). The variant is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000438659 / PMID: 20362275 / 3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

Jul 10, 2024
Dr.Nikuei Genetic Center
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 28, 2019
Mendelics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 20, 2017
Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 13, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: research

- -

-
Suma Genomics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 23, 2021
Illumina Laboratory Services, Illumina
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The FKBP10 c.831dupC (p.Gly278ArgfsTer95) variant results in a frameshift and is predicted to result in premature termination or absence of the protein. In a selection of the literature, the p.Gly278ArgfsTer95 variant has been reported in a homozygous state in at least five affected individuals from three unrelated families (Alanay et al. 2010; Shaheen et al. 2011; Kelly et al. 2011), in a compound heterozygous state with another frameshift variant in two affected individuals from one family (Schwarze et al. 2011), and in a compound heterozygous state with a missense variant in two unrelated individuals (Vorster et al. 2017). The affected individuals presented with osteogenesis imperfecta with or without a range of additional phenotypes. In addition, in one study of 91 individuals with non-syndromic osteogenesis imperfecta type 3, the p.Gly278ArgfsTer95 variant was found in a homozygous state in 35/91 (38%) affected individuals who shared the same haplotype (Vorster et al. 2017). In studies on mRNA isolated from patient cells, the p.Gly278ArgfsTer95 was shown to affect mRNA stability resulting in no measurable stable mRNA and absence of protein on Western blotting (Schwarze et al. 2013). The p.Gly278ArgfsTer95 variant was absent from at least 210 ethnically matched control alleles and is found at a frequency of 0.000445 in the African American population of the Genome Aggregation Database. Based on the collective evidence and application of the ACMG criteria, the c.831dupC (p.Gly278ArgfsTer95) variant is classified as pathogenic for osteogenesis imperfecta with or without joint contractures. -

Apr 01, 2023
Clinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Mar 29, 2024
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance: Uncertain significance
Review Status: flagged submission
Collection Method: clinical testing

- -

not provided Pathogenic:6
Mar 31, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 19, 2018
Center for Personalized Medicine, Children's Hospital Los Angeles
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 02, 2025
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 20362275, 31001443, 27509835, 29499418, 28492130, 31429852, 31589614, 37644014, 38178268, 36703223, 37270749, 36655627, 34902613, 32123938, 30755392, 20839288, 29635034, 34173012, 25931047, 26538303, 30993005, 28378777, 28116328, 29158687, 27146342, 23443412, 21670757, 21567934, 22107750, 29620724, 27762305, 27717089, 28346524, 28177155, 22718341, 34743040, 38374194) -

Nov 30, 2019
Blueprint Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 10, 2022
Revvity Omics, Revvity
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change creates a premature translational stop signal (p.Gly278Argfs*95) in the FKBP10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FKBP10 are known to be pathogenic (PMID: 22689593, 22949511). This variant is present in population databases (rs781896189, gnomAD 0.04%). This premature translational stop signal has been observed in individuals with autosomal recessive osteogenesis imperfecta (PMID: 20362275, 26538303, 27509835, 27717089, 27762305). ClinVar contains an entry for this variant (Variation ID: 438659). For these reasons, this variant has been classified as Pathogenic. -

Osteogenesis imperfecta Pathogenic:1
Oct 04, 2024
Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: research

PVS1, PM3_VeryStrong, PM2 -

Abnormality of the skeletal system Pathogenic:1
Jul 10, 2021
Kariminejad - Najmabadi Pathology & Genetics Center
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Bruck syndrome 1 Pathogenic:1
Jun 01, 2011
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Osteogenesis imperfecta type 12 Pathogenic:1
Jun 01, 2011
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Bruck syndrome 1;C3151218:Osteogenesis imperfecta type 11 Pathogenic:1
Apr 15, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs137853883; hg19: chr17-39975558; API